Presentation
Synopsis: In the lecture "PSMA ligand imaging challenges of recurrent prostate cancer" the topic is about recurrent prostate cancer PET/CT diagnostics with two radiopharmaceuticals - 68Ga-PSMA-11 and 18F-PSMA-1007. In Latvia prostate cancer is the leader in oncology for men in terms of incidence. Early diagnostics of recurrent prostate cancer are a cornerstone for further adequate therapy planning, therefore PSMA ligand PET/CT is a great diagnostic tool and a challenge at the same time.
This agenda item is presented in the following session: S5-2 Prostata Imaging
Plenary session
08.10.2022 09:00 - 10:30